Pleurotoxic Drugs—an Update: Someone Else to Blame?
Autor: | Vasileios S. Skouras, Ioannis Kalomenidis |
---|---|
Rok vydání: | 2019 |
Předmět: |
Drug
medicine.medical_specialty Systemic lupus erythematosus business.industry Pleural effusion Drug discontinuation media_common.quotation_subject Pharmaceutical Science Pleural Disorder medicine.disease Clinical Practice Blame Complementary and alternative medicine Medicine Pharmacology (medical) business Intensive care medicine media_common |
Zdroj: | Current Pulmonology Reports. 8:50-59 |
ISSN: | 2199-2428 |
Popis: | To provide an updated summary of the pleurotoxic drugs and their manifestations. Novel antineoplastic agents for the treatment of hematologic and non-hematologic malignancies have been associated with the induction of pleural disorders. Moreover, the list of agents that have been associated with drug-induced lupus pleuritis is steadily increasing. Pleurotoxic medications are agents that may cause pleural disorders, most commonly pleural effusions. Connecting a pleural disorder to a specific drug requires the exclusion of other potential causes combined with resolution of the disorder after drug discontinuation while previous literature reports on similar cases may be of assistance. The incorporation of new therapies into clinical practice over the last few years has exposed medical professionals to areas devoid of a historic evidence base. Thus, drug-induced pleurotoxicity should be always included in the diagnostic approach to the patient with a pleural effusion. |
Databáze: | OpenAIRE |
Externí odkaz: |